Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Orphan drug status sought for Xerecept

Sep. 19, 1997

Potent and selective 5-HT1D agonists under development at MS&D

Sep. 19, 1997

Taisho/Nihon Nohyaku identify potent and selective D4 receptor ligands

Sep. 19, 1997

Janssen discloses new tachykinin antagonists

Sep. 19, 1997

Fournier presents new bradykinin antagonists

Sep. 19, 1997

Guilford presents preclinical results with PARP inhibitor

Sep. 19, 1997

Asta Medica and Wyeth-Ayerst agreement for epilepsy drug

Sep. 18, 1997

October launch for Zanaflex in U.K.

Sep. 18, 1997

Potent and selective N-type calcium channel blockers for stroke

Sep. 18, 1997

FDA panel recommends approval of Anesta's Actiq for cancer pain

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...